PE20090704A1 - Derivados heterociclicos triciclicos - Google Patents
Derivados heterociclicos triciclicosInfo
- Publication number
- PE20090704A1 PE20090704A1 PE2008001616A PE2008001616A PE20090704A1 PE 20090704 A1 PE20090704 A1 PE 20090704A1 PE 2008001616 A PE2008001616 A PE 2008001616A PE 2008001616 A PE2008001616 A PE 2008001616A PE 20090704 A1 PE20090704 A1 PE 20090704A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- cycloalkyl
- tricycle
- hexahydroisocromene
- pirrol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Anesthesiology (AREA)
- Emergency Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
REFERIDA A COMPUESTOS DERIVADOS DE HETEROCICLICOS TRICICLICOS DE FORMULA (I) DONDE R1 ES ALQUILO(C1-C6), ALQUENILO(C2-C6), ALQUINILO(C2-C6), ENTRE OTROS; R2 ES H, CICLOALQUILO(C3-C7), ALQUILO C1.C6, CICLOALQUILO(C3-C7)-ALQUILO(C1-C2), ENTRE OTROS; R3 ES H, ALQUILO(C1-C6), ALCOXI(C1-C4)-ALQUILO(C1-C2),ENTE OTROS; R4 Y R5 SON CADA UNO H, ALQUILO(C1-C6), CICLOALQUILO(C3-C7), ENTRE OTROS; X ES O, S, SO, SO2, ENTRE OTROS; Y1 ES N, CR6; Y2 ES N, CR7; Y3 ES N, CR8; Y4 ES N, CR9, DONDE NO MAS DE UNO DE Y1-Y4 PUEDE SER SIMULTANEAMENTE N; R6, R7 Y R8 SON CADA UNO H, ALQUENILO(C2-C6), ALQUILOXI(C1-C6), ENTRE OTROS; R9 ES H, HALO, CN, ALQUILOXI(C1-C6), ENTRE OTROS; m ES DE 1-2; n ES DE 0-1. SON COMPUESTOS PREFERIDOS: CIS-6-CLORO-1,2,3a,5,9b-HEXAHIDROISOCROMENO[3,4-c]PIRROL; CIS-6-(TRIFLUOROMETIL)-1,2,3,3a,5,9b-HEXAHIDROISOCROMENO[3,4-c]PIRROL; ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS MODULADORES DEL RECEPTOR 5-HT2, UTILES EN EL TRATAMIENTO DE LA OBESIDAD, ESQUIZOFRENIA Y DISFUNCION COGNITIVA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07116561 | 2007-09-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20090704A1 true PE20090704A1 (es) | 2009-06-20 |
Family
ID=39718515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2008001616A PE20090704A1 (es) | 2007-09-17 | 2008-09-16 | Derivados heterociclicos triciclicos |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20100210680A1 (es) |
| EP (1) | EP2203454A1 (es) |
| JP (1) | JP5447380B2 (es) |
| KR (1) | KR20100072027A (es) |
| CN (1) | CN101801980B (es) |
| AR (1) | AR068521A1 (es) |
| AU (1) | AU2008300607B2 (es) |
| BR (1) | BRPI0816992A2 (es) |
| CA (1) | CA2698436A1 (es) |
| CL (1) | CL2008002767A1 (es) |
| CO (1) | CO6260138A2 (es) |
| MX (1) | MX2010002900A (es) |
| NZ (1) | NZ583627A (es) |
| PE (1) | PE20090704A1 (es) |
| RU (1) | RU2010115337A (es) |
| TW (1) | TW200924752A (es) |
| WO (1) | WO2009037220A1 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8518933B2 (en) | 2009-04-23 | 2013-08-27 | Abbvie Inc. | Modulators of 5-HT receptors and methods of use thereof |
| US8546377B2 (en) | 2009-04-23 | 2013-10-01 | Abbvie Inc. | Modulators of 5-HT receptors and methods of use thereof |
| EP2432783B1 (en) * | 2009-05-22 | 2013-05-01 | Abbott Laboratories | Modulators of 5-ht receptors and methods of use thereof |
| RU2015140748A (ru) * | 2010-05-21 | 2018-12-26 | Эббви Инк. | Модуляторы 5-нт рецепторов и способы их применения |
| WO2012030953A1 (en) | 2010-09-01 | 2012-03-08 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level |
| US20120309796A1 (en) | 2011-06-06 | 2012-12-06 | Fariborz Firooznia | Benzocycloheptene acetic acids |
| WO2015066344A1 (en) | 2013-11-01 | 2015-05-07 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
| WO2019170543A1 (en) | 2018-03-07 | 2019-09-12 | Bayer Aktiengesellschaft | Identification and use of erk5 inhibitors |
| KR20250132455A (ko) | 2022-10-25 | 2025-09-04 | 아르투스 테라퓨틱스 인코포레이티드 | 상피 및/또는 내피 장벽 기능을 강화하기 위한 치료제 |
| CN116253627B (zh) * | 2022-12-27 | 2025-09-05 | 大连双硼医药化工有限公司 | 一种合成2-溴-6-羟基苯甲醛的方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4132710A (en) | 1976-12-20 | 1979-01-02 | Ayerst, Mckenna And Harrison, Ltd. | [2]Benzopyrano[3,4-c]pyridines and process therefor |
| US4132709A (en) * | 1976-12-20 | 1979-01-02 | Ayerst, Mckenna & Harrison, Ltd. | [2]Benzopyrano[4,3-c]pyridine derivatives and process therefor |
| NL8005754A (nl) * | 1980-10-18 | 1982-05-17 | Akzo Nv | Benzo 4,5 pyrano 2,3-c pyrrool derivaten. |
| US4666916A (en) * | 1985-11-08 | 1987-05-19 | Ciba-Geigy Corporation | Hexahydro-(1)-benzo-(pyrano and thiopyrano) (4,3-C)pyridines, useful as serotin-2 blocking agents |
| US5049564A (en) * | 1989-11-17 | 1991-09-17 | Abbott Laboratories | 5-HT selective agents |
| ES2090119T3 (es) * | 1988-12-15 | 1996-10-16 | Abbott Lab | Agentes selectivos de 5-ht. |
| GB8917333D0 (en) * | 1989-07-28 | 1989-09-13 | Merck Sharp & Dohme | Therapeutic agents |
| WO1993008166A1 (en) * | 1991-10-24 | 1993-04-29 | The Upjohn Company | Benzo-isoquinoline derivatives and analogs and their use in therapeutics |
| FR2722194B1 (fr) | 1994-07-06 | 1996-08-23 | Adir | Nouveaux derives de benzopyrane, leur procede de preparation et les compositions pharmacuetiques qui les contiennent |
-
2008
- 2008-09-10 TW TW097134706A patent/TW200924752A/zh unknown
- 2008-09-15 NZ NZ583627A patent/NZ583627A/en not_active IP Right Cessation
- 2008-09-15 MX MX2010002900A patent/MX2010002900A/es not_active Application Discontinuation
- 2008-09-15 AU AU2008300607A patent/AU2008300607B2/en not_active Ceased
- 2008-09-15 KR KR1020107008334A patent/KR20100072027A/ko not_active Withdrawn
- 2008-09-15 CN CN200880107460.7A patent/CN101801980B/zh not_active Expired - Fee Related
- 2008-09-15 RU RU2010115337/04A patent/RU2010115337A/ru unknown
- 2008-09-15 CA CA2698436A patent/CA2698436A1/en not_active Abandoned
- 2008-09-15 EP EP08804190A patent/EP2203454A1/en not_active Withdrawn
- 2008-09-15 US US12/678,184 patent/US20100210680A1/en not_active Abandoned
- 2008-09-15 JP JP2010524519A patent/JP5447380B2/ja not_active Expired - Fee Related
- 2008-09-15 BR BRPI0816992 patent/BRPI0816992A2/pt not_active Application Discontinuation
- 2008-09-15 WO PCT/EP2008/062229 patent/WO2009037220A1/en not_active Ceased
- 2008-09-16 AR ARP080104015A patent/AR068521A1/es unknown
- 2008-09-16 PE PE2008001616A patent/PE20090704A1/es not_active Application Discontinuation
- 2008-09-16 CL CL2008002767A patent/CL2008002767A1/es unknown
-
2010
- 2010-03-17 CO CO10031803A patent/CO6260138A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009037220A1 (en) | 2009-03-26 |
| BRPI0816992A2 (pt) | 2015-03-24 |
| AR068521A1 (es) | 2009-11-18 |
| US20100210680A1 (en) | 2010-08-19 |
| CN101801980B (zh) | 2014-03-12 |
| NZ583627A (en) | 2011-08-26 |
| CA2698436A1 (en) | 2009-03-26 |
| AU2008300607A1 (en) | 2009-03-26 |
| CL2008002767A1 (es) | 2009-03-06 |
| EP2203454A1 (en) | 2010-07-07 |
| CN101801980A (zh) | 2010-08-11 |
| AU2008300607B2 (en) | 2013-08-22 |
| JP2010539139A (ja) | 2010-12-16 |
| CO6260138A2 (es) | 2011-03-22 |
| JP5447380B2 (ja) | 2014-03-19 |
| KR20100072027A (ko) | 2010-06-29 |
| MX2010002900A (es) | 2010-03-31 |
| TW200924752A (en) | 2009-06-16 |
| RU2010115337A (ru) | 2011-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20090704A1 (es) | Derivados heterociclicos triciclicos | |
| PE20071245A1 (es) | COMPUESTOS INDOL SULFONAMIDA COMO MODULADORES DEL RECEPTOR DE PROGESTERONA SELECTIVOS (SPRMs) | |
| PE20081887A1 (es) | Nuevo compuesto de adenina | |
| PE20080277A1 (es) | Derivados de azaindol espirociclicos y sustituidos | |
| PE20060555A1 (es) | Derivados de pirrol-oxindol como moduladores del receptor de progesterona | |
| AR059339A1 (es) | Derivados de la cumarina para trastornos proliferativos de celulas, composicion farmaceutica y agente terapeutico que los contiene | |
| PE20050123A1 (es) | Derivados de heteroarilamida benzocondensada de tienopiridinas y composiciones farmaceuticas que los incluyen | |
| PE20090816A1 (es) | Derivados de pirrolopirimidinona como agentes ligandos de los receptores p2x3 | |
| PE20070983A1 (es) | COMPUESTOS DERIVADOS DE 3-DESAZAPURINA COMO AGONISTAS DEL RECEPTOR Toll-LIKE (TLR7) | |
| PE20090510A1 (es) | Combinaciones de drogas para el tratamiento de la distrofia muscular de duchenne | |
| PE20091472A1 (es) | Moduladores de beta-amiloide | |
| PE20050194A1 (es) | Derivados de piridina-2-carboxamida como activadores de glucoquinasa | |
| AR029815A1 (es) | Derivados aza-indolicos, un proceso para su preparacion, composicion farmaceutica, un metodo para su elaboracion y el uso de dichos derivados para la manufactura de un medicamento | |
| PE20081753A1 (es) | Compuestos y composiciones como inhibidores de la proteasa activadora de canal | |
| UY28150A1 (es) | Agentes terapeuticos | |
| AR034203A1 (es) | Derivados de 1-aril- o 1-alquilsulfonilbenzazol como ligandos de 5-hidroxitriptamina-6, un metodo para su preparacion, composicion farmaceutica y el uso de los mismos para la fabricacion de un medicamento | |
| PE20071136A1 (es) | Derivados de anilina sustituida como antagonistas de la histamina h3 | |
| PE20091734A1 (es) | Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso | |
| PE20070793A1 (es) | Compuestos triciclicos que contienen nitrogeno como agentes antibacterianos | |
| PE20080275A1 (es) | Derivados de 5h-benzo[4,5]ciclohepta[1,2]piridina como inhibidores de tirosina quinasa | |
| PE20071064A1 (es) | Derivados de pirrolonaftiridinonas como antibacterianos | |
| PE20130401A1 (es) | Heteroaril-ciclohexil-tetraazabenzo[e]azulenos | |
| PE20090620A1 (es) | Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen | |
| PE20081831A1 (es) | Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona | |
| PE20081375A1 (es) | Derivados octahidro-pirrolo[3,4-c]pirrol como antagonistas del receptor ccr5 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |